YOKNEAM, Israel, April 3, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in April and May:
23rd Annual Needham Virtual Healthcare Conference
Presenters: Moshe Mizrahy, Chief Executive Officer and Chairman, Yair Malca, Chief Financial Officer and Spero Theodorou, Chief Medical Officer
Format: Virtual fireside chat moderated by Michael Matson, CFA and Senior Equity Research Analyst and one-on-one meetings
When: Tuesday, April 9 at 8:00 am ET
A live webcast of the presentation can be accessed here.
BNPP Exane 2nd Annual Aesthetics Day
Presenters: Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer, and Dr. Spero Theodorou, Chief Medical Officer
Format: Virtual fireside chat moderated by Navann Ty, Lead Equity Analyst and one-on-one meetings
When: Tuesday, May 21 at 1:30 pm ET
A replay of webcast of the presentation can be accessed here.
Barclays West Coast Bus Trip
Presenters: Yair Malca, Chief Financial Officer
Format: In-person investor bus tour at InMode's North American headquarters
When: Tuesday, May 21
Location: Irvine, CA
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
This email address is being protected from spambots. You need JavaScript enabled to view it.
917-607-8654
| Last Trade: | US$18.46 |
| Daily Change: | 0.30 1.65 |
| Daily Volume: | 1,167,341 |
| Market Cap: | US$1.410B |
March 03, 2025 February 04, 2025 September 04, 2024 August 06, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
